Difficulty: Medium
Average Score: 80%
Practice
The patient has been receiving magnesium sulfate intravenously for 24
Correct answer
D
Rationale
The correct answer is D: Contact the health care provider. When a patient receiving magnesium sulfate intravenously shows signs of hypermagnesemia such as 2+ patellar reflexes and negative ankle clonus, it indicates a potential magnesium toxicity. Contacting the healthcare provider is crucial as they can assess the situation, recommend appropriate interventions, adjust the magnesium sulfate dosage, or provide further instructions. Obtaining a stat magnesium sulfate level (choice B) may confirm the high magnesium levels but does not provide immediate guidance on managing the patient. Discontinuing magnesium sulfate (choice C) without consulting the healthcare provider can lead to abrupt changes in the patient's condition. Choice A does not address the issue of potential magnesium toxicity and is not the most appropriate action in this scenario.